Cinven is reviewing strategic options for laboratory-services company Synlab International GmbH including a potential sale, people with knowledge of the matter said.
The private equity firm has been speaking with potential advisers and could start a sale process early next year, the people said, asking not to be identified because the information is private. Cinven plans to seek a valuation of about 5.5 billion euros ($6 billion) including debt for Augsburg, Germany-based Synlab, one of the people said.
A sale of Synlab would likely attract other private equity firms, the people said. No final decision has been made, and Cinven could elect to keep the business, the people said. A spokeswoman for Cinven declined to comment, while Synlab didn’t answer phone calls seeking comment.
Cinven first invested in Synlab in June 2015, buying a majority stake from fellow private equity firm BC Partners for about 1.7 billion euros, Bloomberg News reported at the time. It combined the business with Labco SA, which it agreed to buy earlier that year for 1.2 billion euros.
Synlab, led by Chief Executive Officer Mathieu Floreani, also counts Novo A/S and Ontario Teachers’ Pension Plan as minority investors, according to its website. It operates across more than 40 countries, handling more than 500 million clinical tests annually, according to Synlab’s website.
Cinven also owns stakes in retailer Kurt Geiger and German drugmaker Stada Arzneimittel AG, according to its website.
The sale plan comes at a time when Cinven’s rival Apax Partners is also weighing a sale of diagnostic services business Unilabs. The buyout firm is working with advisers at Rothschild & Co. to look at options for the business, people familiar with the matter said last week.
Source: Bloomberg
Can’t stop reading? Read more
Arctos tops $11bn in sports assets, signals confidence in franchise value despite tariff headwinds
Arctos tops $11bn in sports assets, signals confidence in franchise value despite tariff headwinds Arctos has grown its sports-related assets under management to $11.3bn, strengthening its position as the largest private equity investor in North American sports...
Van Lanschot Kempen closes €388m for third European private equity strategy
Van Lanschot Kempen closes €388m for third European private equity strategy Van Lanschot Kempen Investment Management raised €388m for its third European private equity strategy, marking a successful final close following strong demand from private banking clients...
EQT raises over $10bn for Asia-focused fund, eyes record-breaking $14.5bn close
EQT raises over $10bn for Asia-focused fund, eyes record-breaking $14.5bn close EQT has raised more than $10bn for its latest Asia buyout fund, BPEA Private Equity Fund IX, positioning it to potentially surpass the region’s fundraising record as it moves toward a...